Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. [electronic resource]
Producer: 20070405Description: 1027-32 p. digitalISSN:- 1527-7755
- Adult
- Aged
- Aged, 80 and over
- Anemia -- blood
- Canada
- Carcinoma, Non-Small-Cell Lung -- complications
- Double-Blind Method
- Epoetin Alfa
- Erythropoietin -- adverse effects
- Female
- Hematinics -- adverse effects
- Hemoglobins -- metabolism
- Humans
- Kaplan-Meier Estimate
- Lung Neoplasms -- complications
- Male
- Middle Aged
- Neoplasm Staging
- Proportional Hazards Models
- Quality of Life
- Recombinant Proteins
- Thrombosis -- chemically induced
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.